111

FUSEN PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Market capitalization
‪648.91 M‬HKD
−0.05HKD
‪−40.09 M‬HKD
‪625.00 M‬HKD
‪134.22 M‬
Beta (1Y)
0.15

About FUSEN PHARMACEUTICAL CO LTD

Headquarters
Xichuan
Employees (FY)
‪1.15 K‬
Founded
2013
ISIN
KYG370981030
FIGI
BBG00L9J8GG1
Fusen Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceuticals and medical devices. Its products include carbamazepine tablet, bismuth sub carbonate tablet, injection, dextran 40 glucose injection, azithromycin & glucose injection, cimetidine tablet, vitamin U, aluminum hydroxide and magnesium tablet, yuanhu zhitong oral solution, piracetam injection and medical equipment. The company was founded on January 18, 2013 and is headquartered in Xichuan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1652 is 0.87 HKD — it has increased by 2.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange FUSEN PHARMACEUTICAL CO LTD stocks are traded under the ticker 1652.
1652 stock is 15.79% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is FUSEN PHARMACEUTICAL CO LTD there?
Yes, you can track FUSEN PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
1652 stock has fallen by 10.31% compared to the previous week, the month change is a 18.69% fall, over the last year FUSEN PHARMACEUTICAL CO LTD has showed a 34.59% decrease.
1652 net income for the last quarter is ‪−56.97 M‬ HKD, while the quarter before that showed ‪18.61 M‬ HKD of net income which accounts for −406.11% change. Track more FUSEN PHARMACEUTICAL CO LTD financial stats to get the full picture.
Like other stocks, 1652 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FUSEN PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
1652 reached its all-time high on Feb 3, 2020 with the price of 20.00 HKD, and its all-time low was 0.79 HKD and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪1.15 K‬ employees. See our rating of the largest employees — is FUSEN PHARMACEUTICAL CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FUSEN PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FUSEN PHARMACEUTICAL CO LTD stock shows the sell signal. See more of FUSEN PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FUSEN PHARMACEUTICAL CO LTD EBITDA is ‪63.03 M‬ HKD, and current EBITDA margin is 9.84%. See more stats in FUSEN PHARMACEUTICAL CO LTD financial statements.